BNP Paribas decreased its holdings in shares of Agilent Technologies, Inc. (NYSE:A – Free Report) by 17.4% during the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 15,866 shares of the medical research company’s stock after selling 3,333 shares during the quarter. BNP Paribas’ holdings in Agilent Technologies were worth $2,353,000 as of its most recent SEC filing.
Other institutional investors have also bought and sold shares of the company. Livelsberger Financial Advisory bought a new stake in shares of Agilent Technologies in the 3rd quarter valued at approximately $28,000. Crewe Advisors LLC raised its holdings in Agilent Technologies by 114.8% during the 2nd quarter. Crewe Advisors LLC now owns 189 shares of the medical research company’s stock valued at $25,000 after buying an additional 101 shares during the period. Ashton Thomas Securities LLC bought a new stake in Agilent Technologies in the third quarter worth $31,000. Ridgewood Investments LLC bought a new stake in Agilent Technologies in the second quarter worth $29,000. Finally, Fortitude Family Office LLC boosted its stake in Agilent Technologies by 68.3% during the third quarter. Fortitude Family Office LLC now owns 234 shares of the medical research company’s stock worth $35,000 after buying an additional 95 shares during the period.
Insider Buying and Selling at Agilent Technologies
In other news, SVP Dominique Grau sold 9,990 shares of the stock in a transaction on Thursday, September 26th. The stock was sold at an average price of $145.00, for a total transaction of $1,448,550.00. Following the completion of the sale, the senior vice president now owns 40,011 shares in the company, valued at approximately $5,801,595. This represents a 19.98 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink.
Wall Street Analysts Forecast Growth
Read Our Latest Research Report on Agilent Technologies
Agilent Technologies Stock Down 0.1 %
Shares of NYSE A opened at $134.35 on Wednesday. Agilent Technologies, Inc. has a 12-month low of $124.10 and a 12-month high of $155.35. The stock’s fifty day simple moving average is $137.74 and its two-hundred day simple moving average is $137.43. The stock has a market capitalization of $38.60 billion, a PE ratio of 30.40, a price-to-earnings-growth ratio of 5.91 and a beta of 1.07. The company has a current ratio of 1.78, a quick ratio of 1.37 and a debt-to-equity ratio of 0.36.
Agilent Technologies Increases Dividend
The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, January 22nd. Investors of record on Tuesday, December 31st will be given a dividend of $0.248 per share. The ex-dividend date is Tuesday, December 31st. This represents a $0.99 dividend on an annualized basis and a yield of 0.74%. This is an increase from Agilent Technologies’s previous quarterly dividend of $0.24. Agilent Technologies’s dividend payout ratio (DPR) is presently 21.27%.
About Agilent Technologies
Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.
Further Reading
- Five stocks we like better than Agilent Technologies
- Dividend Screener: How to Evaluate Dividend Stocks Before Buying
- Trump Tariffs in Focus: 2 Chinese Stocks to Own and 2 to Avoid
- How to Use the MarketBeat Excel Dividend Calculator
- 2 Generic Drug Stocks Ready to Surge in 2025
- Stock Splits, Do They Really Impact Investors?
- 3 Small-Cap Stocks That Are Ready to Rocket Higher
Want to see what other hedge funds are holding A? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Agilent Technologies, Inc. (NYSE:A – Free Report).
Receive News & Ratings for Agilent Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies and related companies with MarketBeat.com's FREE daily email newsletter.